TUVA BX and iCover stent grafts used in BEVAR for complex aortic aneurysms
Official title: Retrospective Data Collection of the TUVA BX and iCover Stent Grafts Implanted During Branched Endovascular Aortic Repair (BEVAR)
Run by JOTEC GmbH · NCT07540507 · Data updated 2026-11-12
This study looks at whether the TUVA BX and iCover stent grafts used during BEVAR procedures are safe and perform well in real-world patients with complex abdominal or thoracoabdominal aneurysms.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 105 (estimated) |
| Sponsor | JOTEC GmbH Industry-sponsored |
| Locations | 1 site (Heerlen) |
| Status | Recruiting |
| Started | April 14, 2026 |
| Main results expected | September 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | August 6, 2026 |
| Trial ID | NCT07540507 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) who had a completed BEVAR repair for TAAA or complex AAA with TUVA BX or iCover bridging and at least one target vessel connected, and who have completed or will complete 1-year follow-up.
✕Probably not a fit
Patients who had ruptured aneurysms, hemodynamic instability at procedure, or those enrolled in conflicting investigational studies may not derive benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a retrospective, multicenter observational registry evaluating TUVA BX and iCover stent grafts implanted during BEVAR for complex aortic aneurysms. Researchers will collect existing medical records from the index procedure through a 1-year follow-up to assess safety and effectiveness in routine practice. No comparison group is included, and no new treatments or visits are planned beyond standard care. About 105 patients across up to 25 hospitals in Europe, the UK, and Switzerland are expected to participate, with final results anticipated in December 2026.
Why it matters
Potential benefit: If successful, findings could support broader use of TUVA BX and iCover grafts in BEVAR by demonstrating real-world safety and performance.
How similar studies have gone: Previous Registries and observational assessments have provided useful safety and performance data for endovascular devices in similar settings, informing this study’s approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years at the time of index procedure * Patients must have a completed treatment of TAAA or complex AAA treated with E-nside TAAA Multibranch Stent Graft System (E-nside) or E-xtra Design MultiBranch Stent Graft System (EDM) and with at least one target vessel (CT, SMA, LRA, RRA) bridged with any combination of TUVA BX or iCover. * The index procedure was performed after January 2020. * The patient is not deceased and has already completed or expects to complete the 1 year follow-up visit prior to July 2026; or the patient died. * Patients have been consented according to the local regulation. Exclusion Criteria: * Patient treated for ruptured aneurysm or who were otherwise hemodynamically unstable before the procedure. * Patients enrolled in an investigational study that could confound registry endpoints at index procedure. * Patients who developed a new onset of aortic disease (in any segment) since index procedure, potentially having an impact on the performance of the TAAA or TUVA BX /iCover, devices at the discretion of the investigator
Where it's running
-
Zuyderland Medisch Centrum
Heerlen, Netherlands Recruiting
Study contacts
- Study coordinator: Sonia Sole Sanchez
- Email: Sonia-Sole.Sanchez@artivion.com
- Phone: +34 690 8808 46
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heli-FX EndoAnchor system in abdominal aortic aneurysm patients in China
This study tests whether the Heli-FX EndoAnchor device can safely and effectively help seal and fix AAA patients at high risk of endoleaks or migration after repair.
-
Retreatment with the Nectero EAST System for abdominal aortic aneurysm
This will try retreatment with the Nectero EAST System to repair infrarenal abdominal aortic aneurysms in adults who previously received the device under the initial protocol.
-
Abdominal CT offered alongside lung screening for people who have smoked
We will test whether mentioning a possible extra abdominal CT in the lung screening invitation changes whether people aged 55–70 who have ever smoked attend their lung screening appointment.
-
Observational registry for patients treated with GORE® endovascular devices for abdominal aortic aneurysms
This study is tracking patients who have been treated with GORE® devices for abdominal aortic aneurysms to see how they do over the next 10 years.
-
Evaluating outcomes of endovascular abdominal aortic aneurysm repair
This study is testing two different devices for repairing abdominal aortic aneurysms to see which one works better for patients over time.
-
Using Aortoseal to improve AAA endovascular graft procedures
This study is testing a new device called Aortoseal to see if it can help improve the way doctors attach grafts during surgery for people with abdominal aortic aneurysms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.